| Статус: | Recruiting |
| Фаза: | Phase 3 |
| Начало: | 19 января 2022 г. |
| Окончание: | 30 декабря 2023 г. |
| Описание: | The goal of this clinical trial is to assess tolerability, reactogenicity, safety and immunogenicity of the Flu-M Tetra vaccine as compared to the VaxigripTetra vaccine in terms of prevention of influenza in children aged 6 months to 17 years old inclusive. |
| смотреть на ClinicalTrials.gov |